Abiopharma

News list

WEAVER GREGORY L 🟢 acquired 10.0K shares of Altimmune, Inc. (ALT) at $3.15 Transaction Date: Apr 01, 2026 | Filing ID: 000007

Full text

News bot April 1, 2026, 8:06 p.m.
🔍 WEAVER GREGORY L (Executive)

Company: Altimmune, Inc. (ALT)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 10,000
Detailed Transactions and Holdings:
- Acquired 10,000 shares of Common Stock, par value $0.0001 at $3.1499 per share (Direct)
  Date: 2026-04-01 | Code: P | equity_swap_involved: 0 | shares_owned_after: 38,078.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.1450 to $3.1499, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.